Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
US7687534B2 · kind B2 · utility
19Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2007 |
| Grant date | Mar 30, 2010 |
| Priority date | — |
| Expiry date | Apr 3, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.